Remember that p53 is the most researched and published subject in the history of medicine. The fact that Kevetrin is the first drug to be able to activate it is remarkable and to partner that with its safety profile and ability to be combinable makes it a focus of every BP in the world.

I believe most would be stunned at how much attention IPIX has had behind the scenes the past year or two.

I am stunned, though, that not one has had the foresight to throw BIG money at IPIX to try and acquire the whole pipeline. Penny wise and dollar foolish IMO.